ARSHIYANSEArshiya Limited· Travel And TransportMediumNeutral
Announced Tue, 19 May · 20:03 IST

ARSHIYA: Arshiya Limited has submitted to the Exchange, the audited financial results along with the auditor report thereon for the quarter and financial year ended on March 31, 2025.

Going ConcernQualified OpinionResults RestatedRelated Party TransactionsContingent Liabilities IncreasedDebt Equity ThresholdResults View source PDF

ARSHIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹1.20
prior close
₹1.18
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.8-0.8+0.0+0.0+1.7+0.8-1.7-1.7-4.2-10.8-11.7-17.5
Up moveDown movePending
AI summary

Arshiya Limited, under Corporate Insolvency Resolution Process (CIRP) since April 2024, has submitted audited standalone financial results for FY2025. The auditors (ARTHA & Associates) have issued a DISCLAIMER OF OPINION rather than a standard audit opinion, citing inability to obtain sufficient appropriate audit evidence across 12 material areas. Key issues include: revenue of Rs. 31,497.19 lakhs recognized from Ascendas Panvel FTWZ without executed contracts or customer acceptance; Rs. 57,538.95 lakhs in investments/loans to subsidiary under CIRP with no impairment testing; financial guarantees of Rs. 1,22,350 lakhs not fair-valued; and PPE, inventory, and investments lacking impairment assessment. The company reported net loss of Rs. 1,09,446.03 lakhs (vs Rs. 1,17,495.10 lakhs prior year). Consolidated results could not be prepared as subsidiaries are also under CIRP. Total negative equity stands at Rs. 1,44,030.12 lakhs. Directors refused to sign the statements citing disagreement over a Rs. 1,200.04 lakh receivable.

Likely market impact

This is an extremely distressed filing with a disclaimer of opinion—the most severe auditor flag—compounded by ongoing CIRP, massive negative equity, and unverified financial statements. Shareholders face extreme risk as the financial position remains highly uncertain pending CIRP resolution. The stock should be treated as high-risk with no reliable financial picture available.